Pokonza Potassium Chloride Liquid
NDC Package 15370-307-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Pokonza Potassium Chloride (potassium chloride) liquids is a medication a mineral supplement used to treat or prevent low amounts of potassium in the blood. This formulation utilizes a liquid delivery system. Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-307 and is authorized under FDA application NDA206814.

Identification & Billing

NDC Package Code
15370-307-16
Package Description
473 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
15370030716
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pokonza Potassium Chloride
Non-Proprietary Name
Potassium Chloride
Substance Name
Potassium Chloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.

Regulatory & Marketing

Labeler Name
Carwin Pharmaceutical Associates, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA206814
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (15370-307). Click a package code to view its specific billing and regulatory data.

118 mL in 1 BOTTLE
237 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15370-307-16 identifies a specific commercial package of 473 ml in 1 bottle of Pokonza Potassium Chloride, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. This liquid is formulated for oral use and contains potassium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on January 14, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.

How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370030716. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
15370-307-16
11-Digit CMS (5-4-2)
15370-0307-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.